EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT

EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED HODGKIN’S LYMPHOMA UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT

Objective: To identify the prognostic factors in relapsed Hodgkin’s Lymphoma patients with regards to their impact on the outcome of autologous hematopoietic stem cell transplant. Study Design: Retrospective observational study. Place and Duration of Study: Department of Medical Oncology, Shau...

Full description

Bibliographic Details
Main Authors:	Jhanzeb Iftikhar, Hafiz Abubakar Sarwar, Fareeha Sheikh, Mohammad Iqbal Shah, Shafqual Ali Khan, Muhammad Abu Bakar, Neelam Siddiqui
Format:	Article
Language:	English
Published:	Army Medical College Rawalpindi 2021-10-01
Series:	Pakistan Armed Forces Medical Journal
Subjects:	autologous stem cell transplant hodgkin’s lymphoma
Online Access:	https://www.pafmj.org/index.php/PAFMJ/article/view/4132/3632

Similar Items

Characteristics and outcomes of children, adolescents and young adults with relapsed/refractory non-hodgkin lymphoma undergoing autologous stem cell transplant
by: Oren Pasvolsky, et al.
Published: (2023-12-01)

The Efficacy and Safety of Busulfan-Etoposide-Melphalan Regimen in Autologous Stem Cell Transplantation in Relapsed/ Refractory Hodgkin and Non-Hodgkin Lymphoma Patients: “A Single-Center Experience”
by: Ali Eser, et al.
Published: (2021-05-01)

Autologous Stem Cell Transplant in Hodgkin’s and Non-Hodgkin’s Lymphoma, Multiple Myeloma, and AL Amyloidosis
by: Sulaiman Mohammed Alnasser, et al.
Published: (2023-12-01)

Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation
by: Panagiotis Samaras, et al.
Published: (2013-05-01)

Treatment of Hodgkin Lymphoma Relapsed after Autologous Stem Cell Transplantation
by: Eva Domingo-Domènech, et al.
Published: (2020-05-01)

Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma
by: Chen Zhang, et al.
Published: (2023-05-01)

TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA
by: E. A. Baryakh
Published: (2017-06-01)

Mobilization potential of patients with lymphomas and multiple myeloma involved in autologous stem cell transplant
by: Stančev Katarina, et al.
Published: (2020-01-01)

Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin, and non-Hodgkin lymphoma: the first experience from Palestine
by: Riad Amer, et al.
Published: (2022-09-01)

Autologous Stem Cell Transplantation in Hodgkin Lymphoma—Latest Advances in the Era of Novel Therapies
by: Yazeed Samara, et al.
Published: (2022-03-01)

Clinical Efficacy and Prognostic Factors of Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma in 38 Cases
by: HUANG Zhenghua, et al.
Published: (2022-09-01)

The role of transplantation in Hodgkin lymphoma
by: Michael Maranzano, et al.
Published: (2023-01-01)

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2<sup>nd</sup> line treatment before autologous hematopoietic stem cell transplantation (preliminary results)
by: A. A. Mamedova, et al.
Published: (2022-07-01)

Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States
by: John L. Vaughn, et al.
Published: (2021-10-01)

Autologous hematopoietic stem cell transplantation in classical Hodgkin's lymphoma
by: Afonso José Pereira Cortez, et al.
Published: (2011-02-01)

GDP versus ESHAP Regimen in Relapsed and/or Refractory Hodgkin lymphoma: A Comparison Study
by: Mani Ramzi, et al.
Published: (2015-03-01)

Anti-PD1 Consolidation in Patients with Hodgkin Lymphoma at High Risk of Relapse after Autologous Stem Cell Transplantation: A Multicenter Real-Life Study
by: Rosaria De Filippi, et al.
Published: (2022-11-01)

Hodgkin Lymphoma Mimicking Osteomyelitis
by: Aneela Majeed, et al.
Published: (2017-06-01)

PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01)

Efficacy of CEAC regimen before autologous hematopoietic stem cell transplantation for non-Hodgkin lymphoma: analysis of 102 cases
by: YANG Yichun, et al.
Published: (2019-12-01)

Outcomes of Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma Patients at a Tertiary Referral Centre
by: Ajay Prakash, et al.
Published: (2023-04-01)

Nivolumab in relapsed/refractory Hodgkin Lymphoma patients, single center experiences
by: Ramazan Acar, et al.
Published: (2020-12-01)

Brentuximab vedotin in the treatment of relapsed and refractory forms of Hodgkin lymphoma
by: E A Demina
Published: (2016-06-01)

Treatment outcomes in classic Hodgkin lymphoma: 5‐year update from the Brazilian Hodgkin Lymphoma Registry
by: Irene Biasoli, et al.
Published: (2023-11-01)

Outcome of High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma after Different Numbers of Salvage Regimens
by: Jacopo Mariotti, et al.
Published: (2024-01-01)

Stem-Cell Transplantation in Adult Patients with Relapsed/Refractory Hodgkin Lymphoma
by: Sonja Genadieva Stavrik, et al.
Published: (2021-10-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
by: Han-Na Kim, et al.
Published: (2022-01-01)

A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin’s Lymphoma
by: Walter Hanel, et al.
Published: (2023-02-01)

Management of Relapsed Hodgkin Lymphoma During the Second Trimester of Pregnancy: Case Report
by: Fatih Yaman, et al.
Published: (2023-03-01)

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma
by: Selay Lam, et al.
Published: (2011-10-01)

Non-Hodgkin's lymphoma: A review
by: Rohit Singh, et al.
Published: (2020-01-01)

Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience
by: Talita Máira Bueno da Silveira da Rocha, et al.

Unilateral Ptosis in an Older Adult; a Rare Presentation of Primary Extranodal Hodgkin’s Lymphoma
by: Insija Ilyas Selene, et al.
Published: (2022-02-01)

Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report
by: Ken Tanaka, et al.
Published: (2023-11-01)

Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
by: Hadis Kiani, et al.
Published: (2016-05-01)

IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma
by: Mohammadali Mashhadi, et al.
Published: (2011-09-01)

IEV (Ifosfamide, Epirubicin, VP16) Regimen as Salvage Therapy for Early Relapsed/Refractory non-Hodgkin/Hodgkin Lymphoma
by: Behrooz Najafi, et al.
Published: (2011-10-01)

The Treatment of Non-Hodgkin's Lymphomas
by: David J. Straus
Published: (2023-08-01)

Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
by: Sylvia Hartmann, et al.
Published: (2021-10-01)

Rare Case of Non-Hodgkin’s Lymphoma of the Thyroid
by: Srirama Bhat, et al.
Published: (2020-05-01)